Allen King is a pharmaceutical executive with over 20 years of experience in pricing and market access, specializing in global market access strategy and health economics. Allen's career includes significant roles at major companies like Pfizer, where they currently lead a team focused on global market access for hemophilia gene therapies, and AstraZeneca, where they were responsible for integrating payer needs into clinical trial designs. Educated at NC State University and Duke University, Allen has a proven track record of building successful teams and strategies in both established and emerging markets. Their leadership style emphasizes trust and autonomy, fostering a collaborative environment for team success.
This person is not in the org chart
This person is not in any teams
This person is not in any offices